These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

716 related articles for article (PubMed ID: 22816783)

  • 1. Polydispersity characterization of lipid nanoparticles for siRNA delivery using multiple detection size-exclusion chromatography.
    Zhang J; Haas RM; Leone AM
    Anal Chem; 2012 Jul; 84(14):6088-96. PubMed ID: 22816783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the heterogeneity level in lipid nanoparticles for siRNA delivery: size-based separation, compositional heterogeneity, and impact on bioperformance.
    Zhang J; Pei Y; Zhang H; Wang L; Arrington L; Zhang Y; Glass A; Leone AM
    Mol Pharm; 2013 Jan; 10(1):397-405. PubMed ID: 23210488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.
    Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D
    Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of lipid nanoparticles by Cryo-EM for characterizing siRNA delivery vehicles.
    Crawford R; Dogdas B; Keough E; Haas RM; Wepukhulu W; Krotzer S; Burke PA; Sepp-Lorenzino L; Bagchi A; Howell BJ
    Int J Pharm; 2011 Jan; 403(1-2):237-44. PubMed ID: 20974237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an advanced separation and characterization platform for mRNA and lipid nanoparticles using multi-detector asymmetrical flow field-flow fractionation.
    Gao Z; Lin J; Su WC; Zhang K; Gruenhagen J; Zhong W; Fan Y; Bian J
    Anal Bioanal Chem; 2024 Oct; 416(24):5281-5293. PubMed ID: 39102094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Microfluidic-Based Post-Treatment Process for Size-Controlled Lipid Nanoparticles and Application to siRNA Delivery.
    Kimura N; Maeki M; Sato Y; Ishida A; Tani H; Harashima H; Tokeshi M
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):34011-34020. PubMed ID: 32667806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow field-flow fractionation for the analysis of nanoparticles used in drug delivery.
    Zattoni A; Roda B; Borghi F; Marassi V; Reschiglian P
    J Pharm Biomed Anal; 2014 Jan; 87():53-61. PubMed ID: 24012480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enabling online determination of the size-dependent RNA content of lipid nanoparticle-based RNA formulations.
    Jia X; Liu Y; Wagner AM; Chen M; Zhao Y; Smith KJ; Some D; Abend AM; Pennington J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Dec; 1186():123015. PubMed ID: 34741934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery.
    Mildner R; Hak S; Parot J; Hyldbakk A; Borgos SE; Some D; Johann C; Caputo F
    Eur J Pharm Biopharm; 2021 Jun; 163():252-265. PubMed ID: 33745980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetrical flow field-flow fractionation and multiangle light scattering for analysis of gelatin nanoparticle drug carrier systems.
    Fraunhofer W; Winter G; Coester C
    Anal Chem; 2004 Apr; 76(7):1909-20. PubMed ID: 15053651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring Particle Size Distribution by Asymmetric Flow Field Flow Fractionation: A Powerful Method for the Preclinical Characterization of Lipid-Based Nanoparticles.
    Caputo F; Arnould A; Bacia M; Ling WL; Rustique E; Texier I; Mello AP; Couffin AC
    Mol Pharm; 2019 Feb; 16(2):756-767. PubMed ID: 30604620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based analysis of impact of siRNA mixing conditions on internal structure of siRNA-loaded LNP.
    Ueda K; Sakagawa Y; Saito T; Sakuma F; Tanaka H; Akita H; Higashi K; Moribe K
    J Control Release; 2024 Sep; 373():738-748. PubMed ID: 39053648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering.
    Bunjes H; Unruh T
    Adv Drug Deliv Rev; 2007 Jul; 59(6):379-402. PubMed ID: 17658653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of branched ultrahigh molar mass polymers by asymmetrical flow field-flow fractionation and size exclusion chromatography.
    Otte T; Pasch H; Macko T; Brüll R; Stadler FJ; Kaschta J; Becker F; Buback M
    J Chromatogr A; 2011 Jul; 1218(27):4257-67. PubMed ID: 21238968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetrical flow field-flow fractionation with multi-angle light scattering and quasi elastic light scattering for characterization of poly(ethyleneglycol-b-ɛ-caprolactone) block copolymer self-assemblies used as drug carriers for photodynamic therapy.
    Ehrhart J; Mingotaud AF; Violleau F
    J Chromatogr A; 2011 Jul; 1218(27):4249-56. PubMed ID: 21300359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
    Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
    J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid discovery of potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation.
    Chen D; Love KT; Chen Y; Eltoukhy AA; Kastrup C; Sahay G; Jeon A; Dong Y; Whitehead KA; Anderson DG
    J Am Chem Soc; 2012 Apr; 134(16):6948-51. PubMed ID: 22475086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient down-regulation of CDK4 by novel lipid nanoparticle-mediated siRNA delivery.
    Wang X; Yu B; Wu Y; Lee RJ; Lee LJ
    Anticancer Res; 2011 May; 31(5):1619-26. PubMed ID: 21617218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vast majority of nucleic acid-loaded lipid nanoparticles contain cargo.
    Münter R; Larsen JB; Andresen TL
    J Colloid Interface Sci; 2024 Nov; 674():139-144. PubMed ID: 38925059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.